Cancer
New cancer findings from University Medical Center, Department of Medical Oncology published
Published in Fitness and Wellness Business Week, August 22nd, 2007
A report, "Long-term effects of 7-monohydroxyethylrutoside (monoHER) on DOX-induced cardiotoxicity in mice," is newly published data in Cancer Chemotherapy and Pharmacology. "Doxorubicin (DOX) is a potent antitumor agent for different types of cancer, but the cumulative, dose-related cardiotoxicity limits its clinical use. The incidence of abnormal cardiac function after treatment with DOX appears to increase with time," researchers in Amsterdam, Netherlands report.
"Therefore, late cardiotoxicity is-especially in young surviving patients-a major concern. The aim of this study was to evaluate in mice whether the semisynthetic flavonoid 7-monohydroxyethylrutoside...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness and Wellness Business Week
More Articles from Fitness and Wellness Business Week
- Acne Vulgaris Prevention
Reports from Royal Melbourne Institute of Technology advance knowledge in acne vulgaris prevention - Algorithms
New algorithms research from J. Lim and colleagues discussed - Analytical Chemistry
New analytical chemistry study findings recently were reported by researchers at University of Missouri - Angiotensins
Research from H.L. Li and co-authors provides new data about angiotensins - Apoptosis Cell Biology
Researchers at Pusan National University, Department of Physiology publish new data on apoptosis cell biology - Applied Genetics
Research reports on applied genetics from National Chemical Laboratory provide new insights - More from this issue of Fitness and Wellness Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
